Health Care & Life Sciences » Pharmaceuticals | MaYinglong Pharmaceutical Group Co. Ltd.

MaYinglong Pharmaceutical Group Co. Ltd. | Mutual Funds

Mutual Funds that own MaYinglong Pharmaceutical Group Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Great Wall Selected Blue Chip Fund
5,000,064
1.15%
0
2.61%
12/31/2017
Invesco Great Wall Core Competence Equity Fund
3,000,000
0.7%
-2,000,063
2.66%
12/31/2017
Huaan Mid/Small Cap Fund
2,000,040
0.47%
1,000,040
1.86%
12/31/2017
1,421,181
0.33%
-407,910
0.05%
12/31/2017
Nanfang CSI 500 ETF
1,307,799
0.3%
-52,900
0.14%
12/31/2017
Lion Small Cap Equities Selected Fund
1,299,934
0.3%
-899,918
2.29%
12/31/2017
833,969
0.19%
-561,921
0.4%
12/31/2017
UBS (Lux) Inst. SICAV II - China A Opportunity
754,200
0.18%
0
0.2%
01/31/2018
660,000
0.15%
260,000
1.76%
12/31/2017
Huaan Innovation Fund
658,700
0.15%
658,700
0.48%
12/31/2017

About MaYinglong Pharmaceutical Group Co.

View Profile
Address
No. 100 Zhoujiawan
Wuhan Hubei 430064
China
Employees -
Website -
Updated 07/08/2019
Mayinglong Pharmaceutical Group Co., Ltd. engages in the manufacture of pharmaceutical products. It involves in the following business activities through its subsidiaries: operation of anorectal hospitals and clinics; and retail and wholesale of medicines. Its products include hemorrhoids cream, treatment for skin disease, and cough suppressants.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.